Filter
2034
Text search:
mass
drug
Featured
Recommendations
195
New Publications
548
Language
Document type
No document type
1120
Studies & Reports
364
Guidelines
264
Manuals
112
Strategic & Response Plan
99
Fact sheets
28
Training Material
27
Situation Updates
8
Infographics
6
Resource Platforms
3
Online Courses
2
Brochures
1
Countries / Regions
India
139
Global
98
Kenya
63
Ethiopia
60
Uganda
58
Tanzania
45
South Africa
43
Nigeria
40
Liberia
39
Nepal
38
Bangladesh
38
Western and Central Europe
38
Sierra Leone
37
Zambia
37
Malawi
35
Rwanda
33
Ghana
31
Myanmar / Burma
29
Philippines
26
Latin America and the Carribbean
26
Namibia
24
Africa
24
Ukraine
21
Cambodia
20
Eastern Europe
19
Zimbabwe
16
South–East Asia Region
16
Asia
13
Senegal
12
Indonesia
12
Mozambique
12
Syria
11
Lesotho
11
Congo, Democratic Republic of
10
Russia
10
Eswatini/ Swaziland
9
Botswana
9
West and Central Africa
9
Brazil
7
East and Southern Africa
7
Pakistan
6
South Sudan
6
Thailand
6
Vietnam
6
Guinea
5
Haiti
5
Germany
5
Eastern Europe and Central Asia
5
Laos
5
Burkina Faso
4
USA
4
Afghanistan
4
China
4
Sudan
4
Peru
4
Middle East and North Africa
4
Western Pacific Region
4
Timor Leste/ East Timor
4
Cameroon
3
Somalia
3
Iraq
3
Turkey
3
Colombia
3
El Salvador
3
Sri Lanka
3
Yemen
3
Bhutan
3
Venezuela
3
Iran
3
Georgia
3
North America
3
United Kingdom
3
Mali
2
Saudi Arabia
2
Jordan
2
Lebanon
2
Papua New Guinea
2
Central African Republic
2
Argentina
2
Bolivia
2
Libya
2
Madagascar
2
Mexico
2
Albania
2
Tajikistan
2
Morocco
1
Egypt
1
Chad
1
Gambia
1
North Macedonia
1
Switzerland
1
Honduras
1
Ecuador
1
Greece
1
Angola
1
Chile
1
Poland
1
Palestine
1
North Korea
1
Djibouti
1
Armenia
1
Mongolia
1
Southern Africa
1
Canada
1
Kyrgyzstan
1
Kazakhstan
1
Turkmenistan
1
France
1
Tunisia
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
890
Clinical Guidelines
185
Public Health
129
Key Resources
73
Women & Child Health
61
Capacity Building
24
Pharmacy & Technologies
17
Annual Report MEDBOX
1
Toolboxes
NTDs
179
TB
144
HIV
129
Mental Health
118
COVID-19
92
AMR
71
NCDs
69
Malaria
61
Pharmacy
47
Planetary Health
40
Rapid Response
35
Caregiver
35
Conflict
33
Refugee
31
Ebola & Marburg
27
Global Health Education
26
Cholera
15
Natural Hazards
12
Specific Hazards
12
2.0 Rapid Response
12
Health Financing Toolbox
11
Disability
9
Social Ethics
7
Zika
5
Polio
4
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn
...
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis,
...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
Accessed on 31.03.2023
COUNTDOWN Nigeria has applied a Participatory Action Research (PAR) approach to improve equity of Mass Administration of Medicines (MAM) and inform Neglected Tropical Disease (NTD) policy through an enhanced community enga
...
Parasite Epidemiology and Control Volume 27, November 2024, e00380
The planning and implementation of intervention measures against schistosomiasis, particularly mass administration, require knowledge of the current status of the infection. This is
...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a
...
Tuberculosis treatment failure results in increased risk of morbidity, drug resistance, transmission and mortality. There are few data about tuberculosis treatment outcomes in Burkina Faso. The current study investigated the factors associated with
...
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resis
...
PLOS Glob Public Health 4(12): e0004035. https://doi. org/10.1371/journal.pgph.0004035.
A new formulation of praziquantel, arpraziquantel (arPZQ), has been developed for preschool-
aged children (PSAC) to fill the treatment gap for this age group in schistosomiasis control and
elimination program
...
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i
...
This report presents the findings of the Estimating the Size of Populations through a Household Survey (ESPHS) study that took place in 2011. The study utilized a single household survey to estimate the size of several key populations, including sex workers, men who have sex with men (MSM), injectin
...
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n
...
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi
...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been develop
...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread
...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment
...
The Cholera Q&A Fact Sheet provides essential information about cholera, including its causes, symptoms, treatment, and prevention. Cholera is an acute diarrheal disease caused by Vibrio cholerae, which spreads through contaminated water and food. It leads to rapid dehydration and can be fatal if un
...
